Aptevo Therapeutics Net Worth 2014-2021 | APVO
Interactive chart of historical net worth (market cap) for Aptevo Therapeutics (APVO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Aptevo Therapeutics net worth as of October 15, 2021 is $0.07B.
||Medical - Biomedical and Genetics
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.